
All FDA warnings are at the end of this fact sheet. Please consult them before taking this medication.
Paliperidone is a second generation antipsychotic (SGA) medication approved for the treatment of schizophrenia. Paliperidone can improve symptoms of schizophrenia such as hallucinations, delusions and disorganized thinking; in some people, improvement in social isolation, reduced speech productivity and motivation also occur.
Relapse is very common in schizophrenia and the most frequent cause is that patients stop taking their medication. Even when medication is taken exactly as prescribed, relapse may still occur for some people. Therefore it is recommended that you take your medication exactly as prescribed by your health care provider as this has been shown to decrease relapse.
If you are planning on becoming pregnant, notify your health care provider so that he/she can best manage your medications. People living with schizophrenia who wish to become pregnant face important decisions, each with risks and benefits related to how the illness, medications and the risks to the fetus may interact. This is a complex decision as untreated schizophrenia has risks to the fetus as well as the mother. There are many dimensions to these choices, so be sure to confer with your doctor and caregivers.
Regarding breast-feeding, caution is advised since paliperidonedoes pass into breast milk.
Symptoms of schizophrenia which are bothersome to you.
If you had any serious side effects with other antipsychotic medications like muscle stiffness, muscle cramping, shaking, tardive dyskinesia, neuroleptic malignant syndrome, weight gain or diabetes. (For more information, see the NAMI Hearts and Minds Program.)
If you have had an allergic reaction to paliperidone or risperidone or any other medication.
History of heart problems, such as, heart rhythm problems, long QT syndrome or heart attacks. These illnesses may make paliperidone unsafe for you to take
Medical problems you have, especially diabetes, high cholesterol or triglycerides, increased body weight, seizures or kidney disease or impairment.
If you miss a dose of paliperidone, take it as soon as you remember it, if it is not too close to when your next dose is due—discuss this with your health care provider. Do not double your next dose or take more than what is prescribed. If it has been longer than six weeks since your last injection, your health care provider may give extra injections.
If an overdose occurs, whether intentional or accidental, immediate medical attention may be necessary. Call your doctor or emergency medical service (911). You may also contact the poison control center at 1 (800) 222-1222.
Side effects that are usually relatively minor include low blood pressure or dizziness, especially when standing up suddenly; sleepiness; constipation; weight gain; sexual dysfunction; and fatigue. Some of these problems may be reduced by increasing the dose slowly. Patients who already have low blood pressure, have kidney or liver impairment, are elderly or are in a weakened condition may require close monitoring and even more gradual dose adjustment.
Paliperidone may increase the blood levels of a hormone called prolactin. Side effects of increased prolactin levels include females losing their period, production of breast milk and males losing their sex drive or possibly experiencing erectile problems. Long term (months or years) of elevated prolactin can lead to softer bones, osteoporosis or increased risk of bone fractures. Contact your doctor if these symptoms occur or to discuss any concerns.
What are the more serious side effects of antipsychotics?
Please let your doctors know if you have any of these medical conditions prior to starting paliperidone.
It is important to be aware of prevention with attention to nutrition, exercise and reducing your plate size (because the medications may reduce your ability to feel full after eating). For more ideas, see the NAMI Hearts & Minds Program.
Also, obtain Abnormal Involuntary Movement testing (AIMS) to monitor for TD. While it is less common with newer SGA, it has been reported. If you are taking an older FGA, then regular AIMS testing is needed for monitoring, so you can make good choices about the use of the drug when weighing the risks and benefits.
Tardive dyskinesia (TD) is a side effect that develops with prolonged use of antipsychotics. Medications such as paliperidone have been shown to have a much lower risk of TD compared to older antipsychotics, such as Haldol® (haloperidol). Should you develop symptoms of TD, such as grimacing, sucking and smacking of lips and other movements that you cannot control, contact your health care provider immediately.
No one can predict how much weight a person will gain on any medicine, but an approach that includes exercise and diet and monitoring for weight gain and diabetes is recommended.
Paliperidone may cause changes to your heart rhythm. If you are currently taking medications for heart rhythm problems such as amiodarone (Cordarone®, Pacerone®), disopyramide (Norpace®), sotalol (Betapace®) and others so talk with your doctor prior to starting paliperidone.
Paliperidone may potentially lower one’s blood pressure, so caution needs to be used with other agents that may decrease your blood pressure.
Paliperidone may block the effects of agents used to treat Parkinson’s disease such as levodopa (Sinemet®), bromocriptine, pramipexole (Mirapex®), ropinirole (Requip®) and others.
Paliperidone rebalances dopamine and serotonin to improve thinking, mood and behavior. Improvement of some symptoms may be noticed in some patients within a few weeks. The full benefit of paliperidone may not be seen for six to 12 weeks or longer.
Both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. |
Updated by Elizabeth A. Eichel-Bato, Pharm.D., BCPP, BCPS
(December 2010)
NAMI wishes to thank the College of Psychiatric and Neurologic Pharmacists for producing this fact sheet.
Reviewed by Dr. Ken Duckworth, NAMI Medical Director
Copyright © 1996 - 2011 NAMI. All Rights Reserved.